A new study conducted in the U.S. Food and Drug Administration’s (FDA) laboratory reveals radically high levels of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.
Tests conducted at the FDA’s White Oak Campus in Maryland showed residual DNA levels exceeded regulatory safety limits by 6 to 470 times.
The peer-reviewed study was undertaken by three student researchers under the supervision of FDA scientists. It was
published in the
Journal of High School Science on December 29, 2024.
“
These findings are significant not just for what they reveal but for what they suggest has been concealed from public scrutiny. Why has the FDA kept these data under wraps?” McKernan said.
McKernan said the contamination suggests vaccine recipients were at a higher risk of cancer due to genome integration and another way. Plasmid DNA fragments entering the cell's cytoplasm with the help of lipid nanoparticles, could
overstimulate the cGAS-STING pathway, a crucial component of the innate immune response.
“Repeated exposure to foreign DNA through COVID-19 boosters may amplify this risk over time, creating conditions conducive to cancer development,” McKernan said.
